Pre-emptive therapy with rituximab for prevention of Epstein-Barr virus-associated lymphoproliferative disease after hematopoietic stem cell transplantation. - Gruhn,B.; Meerbach,A.; Hafer,R. (Bone Marrow Transplant, 2003)